Lisata Therapeutics, Inc.LSTANASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P21
Within normal range
vs 5Y Ago
-2.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-13.62%
2024-6.93%
2023-8.25%
202223.24%
202115.99%
20206.42%
2019-1.04%
2018-20.06%
2017-8.22%
2016-57.33%